Mucosal exposure to non-tuberculous mycobacteria elicits B cell-mediated immunity against pulmonary tuberculosis-Reference-Cited by-同舟云学术

Mucosal exposure to non-tuberculous mycobacteria elicits B cell-mediated immunity against pulmonary tuberculosis

Published:2022-12 Issue:11 Volume:41 Page:111783
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Dutt Taru S.^ORCID,Karger Burton R.,Fox Amy,Youssef Nathan,Dadhwal Rhythm,Ali Malik Zohaib,Patterson Johnathan,Creissen Elizabeth,Rampacci Elisa,Cooper Sarah K.,Podell Brendan K.,Gonzalez-Juarrero Mercedes,Obregon-Henao Andres,Henao-Tamayo Marcela^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference109 articles.

1. The rise of non-tuberculosis mycobacterial lung disease;Ratnatunga;Front. Immunol.,2020

2. Nontuberculous mycobacterial infections;Desai;JAMA,2021

3. Non-tuberculous mycobacteria: classification, diagnostics, and therapy;Porvaznik;Adv. Exp. Med. Biol.,2017

4. General overview of nontuberculous mycobacteria opportunistic pathogens: Mycobacterium avium and Mycobacterium abscessus;To;J. Clin. Med.,2020

5. The success and failure of BCG — implications for a novel tuberculosis vaccine;Andersen;Nat. Rev. Microbiol.,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneity in immune cell composition is associated with Mycobacterium tuberculosis replication at the granuloma level;Frontiers in Immunology;2024-08-26

2. A Modified BPaL Regimen for Tuberculosis Treatment replaces Linezolid with Inhaled Spectinamides;2024-08-14

3. A Modified BPaL Regimen for Tuberculosis Treatment replaces Linezolid with Inhaled Spectinamides;2024-08-14

4. Immunogenicity and vaccine potential of clinical isolate Mycobacterium kansasii strain against Mycobacterium tuberculosis infection;Microbiology Spectrum;2024-08-06

5. Phytochemicals: a promising approach to control infectious bursal disease;Frontiers in Veterinary Science;2024-06-11